首页 > 最新文献

Diagnosis最新文献

英文 中文
What is diagnostic safety? A review of safety science paradigms and rethinking paths to improving diagnosis. 什么是诊断安全?回顾安全科学范例,重新思考改进诊断的途径。
IF 2.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-27 eCollection Date: 2024-11-01 DOI: 10.1515/dx-2024-0008
Justin J Choi

Diagnostic errors in health care are a global threat to patient safety. Researchers have traditionally focused diagnostic safety efforts on identifying errors and their causes with the goal of reducing diagnostic error rates. More recently, complementary approaches to diagnostic errors have focused on improving diagnostic performance drawn from the safety sciences. These approaches have been called Safety-II and Safety-III, which apply resilience engineering and system safety principles, respectively. This review explores the safety science paradigms and their implications for analyzing diagnostic errors, highlighting their distinct yet complementary perspectives. The integration of Safety-I, Safety-II, and Safety-III paradigms presents a promising pathway for improving diagnosis. Diagnostic researchers not yet familiar with the various approaches and potential paradigm shift in diagnostic safety research may use this review as a starting point for considering Safety-I, Safety-II, and Safety-III in their efforts to both reduce diagnostic errors and improve diagnostic performance.

医疗诊断错误是对患者安全的全球性威胁。传统上,研究人员将诊断安全工作的重点放在识别错误及其原因上,目的是降低诊断错误率。最近,针对诊断错误的补充方法则侧重于从安全科学中汲取营养,提高诊断性能。这些方法被称为 Safety-II 和 Safety-III,分别应用了弹性工程和系统安全原则。本综述探讨了安全科学范式及其对分析诊断错误的影响,强调了它们不同但互补的观点。安全-I、安全-II 和安全-III 范式的整合为改进诊断提供了一条大有可为的途径。尚未熟悉诊断安全研究中的各种方法和潜在范式转变的诊断研究人员可将本综述作为起点,在努力减少诊断错误和提高诊断绩效的过程中考虑安全-I、安全-II 和安全-III 范式。
{"title":"What is diagnostic safety? A review of safety science paradigms and rethinking paths to improving diagnosis.","authors":"Justin J Choi","doi":"10.1515/dx-2024-0008","DOIUrl":"10.1515/dx-2024-0008","url":null,"abstract":"<p><p>Diagnostic errors in health care are a global threat to patient safety. Researchers have traditionally focused diagnostic safety efforts on identifying errors and their causes with the goal of reducing diagnostic error rates. More recently, complementary approaches to diagnostic errors have focused on improving diagnostic performance drawn from the safety sciences. These approaches have been called Safety-II and Safety-III, which apply resilience engineering and system safety principles, respectively. This review explores the safety science paradigms and their implications for analyzing diagnostic errors, highlighting their distinct yet complementary perspectives. The integration of Safety-I, Safety-II, and Safety-III paradigms presents a promising pathway for improving diagnosis. Diagnostic researchers not yet familiar with the various approaches and potential paradigm shift in diagnostic safety research may use this review as a starting point for considering Safety-I, Safety-II, and Safety-III in their efforts to both reduce diagnostic errors and improve diagnostic performance.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":"369-373"},"PeriodicalIF":2.2,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141097125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should APTT become part of thrombophilia screening? APTT 是否应成为血栓性疾病筛查的一部分?
IF 2.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-24 eCollection Date: 2024-11-01 DOI: 10.1515/dx-2024-0086
Giuseppe Lippi, Emmanuel J Favaloro
{"title":"Should APTT become part of thrombophilia screening?","authors":"Giuseppe Lippi, Emmanuel J Favaloro","doi":"10.1515/dx-2024-0086","DOIUrl":"10.1515/dx-2024-0086","url":null,"abstract":"","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":"343-344"},"PeriodicalIF":2.2,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141081053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent mortality rates due to complications of medical and surgical care in the US. 美国医疗和外科护理并发症导致的最新死亡率。
IF 2.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-20 eCollection Date: 2024-11-01 DOI: 10.1515/dx-2024-0071
Camilla Mattiuzzi, Mario Plebani, Giuseppe Lippi

Objectives: Medical errors and complications pose a major threat to the safety of healthcare systems worldwide. This article was hence aimed at determining the current burden of complications of medical and surgical care in the US.

Methods: We searched the latest version of the US Centers for Disease Control and Prevention (CDC) WONDER online database (years 2018-2022) using ICD-10 codes Y40-Y84 (complications of medical and surgical care).

Results: The age-adjusted death rate for complications of medical and surgical care increased from 1.17 × 100,000 in 2018 to 1.49 × 100,000 in 2021, but then declined to 0.85 × 100,000 in 2022. The gender-specific analysis showed a similar trend, with the age-adjusted death rate values always being higher in men than in women. A clear age-dependent relationship was also found in the crude mortality rate for complications of medical and surgical care, as higher death rates were observed in older patients.

Conclusions: This analysis reveals that the burden of complications of medical and surgical care has increased over time, especially during the COVID-19 pandemic, but has then considerably declined in 2022. However, root cause analysis and actions are still needed for preventing the still noticeable consequences of medical complications.

目的:医疗事故和并发症对全球医疗系统的安全构成了重大威胁。因此,本文旨在确定当前美国医疗和外科护理并发症的负担:我们使用ICD-10代码Y40-Y84(内外科护理并发症)检索了美国疾病控制和预防中心(CDC)WONDER在线数据库的最新版本(2018-2022年):经年龄调整后的内外科护理并发症死亡率从2018年的1.17×100,000上升至2021年的1.49×100,000,但随后下降至2022年的0.85×100,000。性别分析显示了类似的趋势,男性的年龄调整后死亡率值始终高于女性。在内科和外科护理并发症的粗死亡率方面,也发现了明显的年龄依赖关系,因为年龄较大的患者死亡率较高:这项分析表明,医疗和外科护理并发症的负担随着时间的推移而增加,尤其是在 COVID-19 大流行期间,但随后在 2022 年大幅下降。然而,仍需对根本原因进行分析并采取行动,以预防医疗并发症带来的明显后果。
{"title":"Recent mortality rates due to complications of medical and surgical care in the US.","authors":"Camilla Mattiuzzi, Mario Plebani, Giuseppe Lippi","doi":"10.1515/dx-2024-0071","DOIUrl":"10.1515/dx-2024-0071","url":null,"abstract":"<p><strong>Objectives: </strong>Medical errors and complications pose a major threat to the safety of healthcare systems worldwide. This article was hence aimed at determining the current burden of complications of medical and surgical care in the US.</p><p><strong>Methods: </strong>We searched the latest version of the US Centers for Disease Control and Prevention (CDC) WONDER online database (years 2018-2022) using ICD-10 codes Y40-Y84 (complications of medical and surgical care).</p><p><strong>Results: </strong>The age-adjusted death rate for complications of medical and surgical care increased from 1.17 × 100,000 in 2018 to 1.49 × 100,000 in 2021, but then declined to 0.85 × 100,000 in 2022. The gender-specific analysis showed a similar trend, with the age-adjusted death rate values always being higher in men than in women. A clear age-dependent relationship was also found in the crude mortality rate for complications of medical and surgical care, as higher death rates were observed in older patients.</p><p><strong>Conclusions: </strong>This analysis reveals that the burden of complications of medical and surgical care has increased over time, especially during the COVID-19 pandemic, but has then considerably declined in 2022. However, root cause analysis and actions are still needed for preventing the still noticeable consequences of medical complications.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":"443-445"},"PeriodicalIF":2.2,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140955507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of heart failure registration in primary care: observations from 1 million electronic health records in the Amsterdam Metropolitan Area. 初级医疗中心力衰竭登记的质量:从阿姆斯特丹大都会区 100 万份电子健康记录中观察到的结果。
IF 2.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-14 eCollection Date: 2024-11-01 DOI: 10.1515/dx-2024-0009
Lukas De Clercq, Jelle C L Himmelreich, Ralf E Harskamp

Objectives: Proper coding of heart failure (HF) in electronic health records (EHRs) is an important prerequisite for adequate care and research towards this vulnerable patient population. We set out to evaluate the accuracy of registration of HF diagnoses in primary care EHRs.

Methods: In a routine primary care database covering the Amsterdam Metropolitan Area, we identified all episodes of care with International Classification of Primary Care (ICPC) codes K77 (decompensatio cordis) or K84.03 (cardiomyopathy) up to 31/12/2021. We also performed two text-based searches to identify HF episodes without an appropriate ICPC-code. An expert panel evaluated all ICPC and text matches for congruence between the assigned codes and notes.

Results: From a database of 968,433 records we identified 19,106 patients (2.0 %) with a total of 24,011 ICPC-coded HF episodes. Removal of 1,324 episodes found to concern other or uncertain diagnoses and inclusion of 4,582 validated HF episodes identified through text search led to exclusion of 909 (overregistration: 4.8 %) and inclusion of 2,266 additional patients (underregistration: 11.1 %). The inclusion of miscoded HF episodes advanced the first known date of HF diagnosis in 3.9 % of records, with a median shift of 3.45 years. Episode-level underregistration decreased significantly over time, from 23.8 % in 2006 to 10.0 % in 2021.

Conclusions: While there is improvement over time, there are still substantial levels of over- and underregistration of HF, emphasizing the need for cautious interpretation of ICPC-coded data. The findings contribute to the understanding of HF registration issues in primary care and provide insights for improving registration practices.

目的:在电子健康记录(EHR)中对心力衰竭(HF)进行正确编码是对这一弱势患者群体进行充分护理和研究的重要前提。我们着手评估基层医疗电子病历中心力衰竭诊断登记的准确性:方法:在覆盖阿姆斯特丹大都会区的常规初级医疗数据库中,我们确定了截至 2021 年 12 月 31 日所有带有国际初级医疗分类 (ICPC) 代码 K77(心肌减压)或 K84.03(心肌病)的医疗事件。我们还进行了两次文本检索,以识别没有相应 ICPC 代码的高频病例。专家小组对所有 ICPC 和文本匹配进行了评估,以确定分配的代码与注释之间是否一致:从 968,433 条记录的数据库中,我们发现了 19,106 名患者(2.0%)共 24,011 次 ICPC 编码的高血压病程。删除了 1324 个涉及其他诊断或不确定诊断的病例,并纳入了 4582 个通过文本搜索确定的有效高血压病例,结果排除了 909 个病例(登记过多:4.8%),纳入了 2266 个额外的病人(登记不足:11.1%)。在 3.9% 的记录中,由于纳入了编码错误的高血压病例,首次确诊高血压的日期提前了,中位数提前了 3.45 年。随着时间的推移,病程水平的登记不足率明显下降,从2006年的23.8%降至2021年的10.0%:虽然随着时间的推移情况有所改善,但仍存在大量的高血压登记过度和登记不足的情况,这强调了谨慎解释 ICPC 编码数据的必要性。研究结果有助于了解基层医疗机构的高血压登记问题,并为改进登记实践提供了启示。
{"title":"Quality of heart failure registration in primary care: observations from 1 million electronic health records in the Amsterdam Metropolitan Area.","authors":"Lukas De Clercq, Jelle C L Himmelreich, Ralf E Harskamp","doi":"10.1515/dx-2024-0009","DOIUrl":"10.1515/dx-2024-0009","url":null,"abstract":"<p><strong>Objectives: </strong>Proper coding of heart failure (HF) in electronic health records (EHRs) is an important prerequisite for adequate care and research towards this vulnerable patient population. We set out to evaluate the accuracy of registration of HF diagnoses in primary care EHRs.</p><p><strong>Methods: </strong>In a routine primary care database covering the Amsterdam Metropolitan Area, we identified all episodes of care with International Classification of Primary Care (ICPC) codes K77 (decompensatio cordis) or K84.03 (cardiomyopathy) up to 31/12/2021. We also performed two text-based searches to identify HF episodes without an appropriate ICPC-code. An expert panel evaluated all ICPC and text matches for congruence between the assigned codes and notes.</p><p><strong>Results: </strong>From a database of 968,433 records we identified 19,106 patients (2.0 %) with a total of 24,011 ICPC-coded HF episodes. Removal of 1,324 episodes found to concern other or uncertain diagnoses and inclusion of 4,582 validated HF episodes identified through text search led to exclusion of 909 (overregistration: 4.8 %) and inclusion of 2,266 additional patients (underregistration: 11.1 %). The inclusion of miscoded HF episodes advanced the first known date of HF diagnosis in 3.9 % of records, with a median shift of 3.45 years. Episode-level underregistration decreased significantly over time, from 23.8 % in 2006 to 10.0 % in 2021.</p><p><strong>Conclusions: </strong>While there is improvement over time, there are still substantial levels of over- and underregistration of HF, emphasizing the need for cautious interpretation of ICPC-coded data. The findings contribute to the understanding of HF registration issues in primary care and provide insights for improving registration practices.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":"380-388"},"PeriodicalIF":2.2,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140916190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unclassified green dots on nucleated red blood cells (nRBC) plot in DxH900 from a patient with hyperviscosity syndrome. 一位高粘度综合征患者的 DxH900 中有核红细胞(nRBC)图上的未分类绿点。
IF 3.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-10 DOI: 10.1515/dx-2024-0038
Rafael José García Martínez, José Carlos Garrido Gomez, Enrique María Ocio San Miguel, María Josefa Muruzábal Sitges

Objectives: Analytical interferences, caused by antibodies, often go unnoticed and require a deep understanding of analyzer principles in the correct clinical context.

Methods: A case report details a 56-year-old man with symptoms of hyperviscosity syndrome (HVS) due to multiple myeloma.

Results: The DxH 900 analyzer revealed abnormalities in the nucleated red blood cell (nRBC) graph, attributed to a high concentration of IgA kappa. Immediate plasmapheresis successfully treated HVS, reducing the monoclonal component and eliminating the aberrant green signal.

Conclusions: In the appropriate clinical context, the recognition of analytical interferences is necessary for accurate clinical interpretation, and it is only possible with knowledge of the analytical principles of the instruments. In this case, the high concentration of IgA kappa generated an aberrant green signal in the VCSm.

目的:由抗体引起的分析干扰往往不被注意,需要在正确的临床背景下深入了解分析仪原理:由抗体引起的分析干扰常常被忽视,需要在正确的临床背景下深入了解分析仪的原理:本病例报告详细描述了一名因多发性骨髓瘤而出现高粘度综合征(HVS)症状的 56 岁男性:结果:DxH 900 分析仪显示有核红细胞(nRBC)图异常,原因是高浓度的 IgA kappa。立即进行血浆置换成功治疗了 HVS,减少了单克隆成分,消除了异常绿色信号:在适当的临床环境中,只有了解仪器的分析原理,才能识别分析干扰,进行准确的临床解释。在本病例中,高浓度的 IgA kappa 在 VCSm 中产生了异常绿色信号。
{"title":"Unclassified green dots on nucleated red blood cells (nRBC) plot in DxH900 from a patient with hyperviscosity syndrome.","authors":"Rafael José García Martínez, José Carlos Garrido Gomez, Enrique María Ocio San Miguel, María Josefa Muruzábal Sitges","doi":"10.1515/dx-2024-0038","DOIUrl":"https://doi.org/10.1515/dx-2024-0038","url":null,"abstract":"<p><strong>Objectives: </strong>Analytical interferences, caused by antibodies, often go unnoticed and require a deep understanding of analyzer principles in the correct clinical context.</p><p><strong>Methods: </strong>A case report details a 56-year-old man with symptoms of hyperviscosity syndrome (HVS) due to multiple myeloma.</p><p><strong>Results: </strong>The DxH 900 analyzer revealed abnormalities in the nucleated red blood cell (nRBC) graph, attributed to a high concentration of IgA kappa. Immediate plasmapheresis successfully treated HVS, reducing the monoclonal component and eliminating the aberrant green signal.</p><p><strong>Conclusions: </strong>In the appropriate clinical context, the recognition of analytical interferences is necessary for accurate clinical interpretation, and it is only possible with knowledge of the analytical principles of the instruments. In this case, the high concentration of IgA kappa generated an aberrant green signal in the VCSm.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140891016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
n-3 fatty acids and the risk of atrial fibrillation, review. n-3 脂肪酸与心房颤动风险,综述。
IF 2.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-09 eCollection Date: 2024-11-01 DOI: 10.1515/dx-2024-0077
Wolfgang Herrmann, Markus Herrmann

Atrial fibrillation (AF) is the most frequent type of cardiac arrhythmia that affects over six million individuals in Europe. The incidence and prevalence of AF rises with age, and often occurs after cardiac surgery. Other risk factors correlated with AF comprise high blood pressure, diabetes mellitus, left atrial enlargement, ischemic heart disease, and congestive heart failure. Considering the high prevalence of AF in aging societies, strategies to prevent serious complications, such as stroke or heart failure, are important because they are correlated with high morbidity and mortality. The supplementation of sea-derived n-3 polyunsaturated fatty acids (PUFA) is widely discussed in this context, but the results of experimental and observational studies are in contrast to randomized placebo-controlled intervention trials (RCTs). Specifically, larger placebo-controlled n-3 PUFA supplementation studies with long follow-up showed a dose-dependent rise in incident AF. Daily n-3 PUFA doses of ≥1 g/d are correlated with a 50 % increase in AF risk, whereas a daily intake of <1 g/d causes AF in only 12 %. Individuals with a high cardiovascular risk (CVD) risk and high plasma-triglycerides seem particularly prone to develop AF upon n-3 PUFA supplementation. Therefore, we should exercise caution with n-3 PUFA supplementation especially in patients with higher age, CVD, hypertriglyceridemia or diabetes. In summary, existing data argue against the additive intake of n-3 PUFA for preventative purposes because of an incremental AF risk and lacking CVD benefits. However, more clinical studies are required to disentangle the discrepancy between n-3 PUFA RCTs and observational studies showing a lower CVD risk in individuals who regularly consume n-3 PUFA-rich fish.

心房颤动(房颤)是最常见的心律失常类型,影响着欧洲 600 多万人。心房颤动的发病率和流行率随着年龄的增长而上升,并且经常发生在心脏手术之后。与房颤相关的其他风险因素包括高血压、糖尿病、左心房扩大、缺血性心脏病和充血性心力衰竭。考虑到心房颤动在老龄化社会中的高发病率,预防中风或心力衰竭等严重并发症的策略非常重要,因为它们与高发病率和高死亡率相关。在这方面,人们广泛讨论了补充海洋萃取的 n-3 多不饱和脂肪酸 (PUFA),但实验和观察性研究的结果与随机安慰剂对照干预试验 (RCT) 形成了鲜明对比。具体而言,长期随访的大型安慰剂对照 n-3 PUFA 补充剂研究显示,房颤发病率的上升与剂量有关。每日 n-3 PUFA 剂量≥1 克/天与房颤风险增加 50% 相关,而每日摄入量≥1 克/天与房颤风险增加 50% 相关。
{"title":"n-3 fatty acids and the risk of atrial fibrillation, review.","authors":"Wolfgang Herrmann, Markus Herrmann","doi":"10.1515/dx-2024-0077","DOIUrl":"10.1515/dx-2024-0077","url":null,"abstract":"<p><p>Atrial fibrillation (AF) is the most frequent type of cardiac arrhythmia that affects over six million individuals in Europe. The incidence and prevalence of AF rises with age, and often occurs after cardiac surgery. Other risk factors correlated with AF comprise high blood pressure, diabetes mellitus, left atrial enlargement, ischemic heart disease, and congestive heart failure. Considering the high prevalence of AF in aging societies, strategies to prevent serious complications, such as stroke or heart failure, are important because they are correlated with high morbidity and mortality. The supplementation of sea-derived n-3 polyunsaturated fatty acids (PUFA) is widely discussed in this context, but the results of experimental and observational studies are in contrast to randomized placebo-controlled intervention trials (RCTs). Specifically, larger placebo-controlled n-3 PUFA supplementation studies with long follow-up showed a dose-dependent rise in incident AF. Daily n-3 PUFA doses of ≥1 g/d are correlated with a 50 % increase in AF risk, whereas a daily intake of <1 g/d causes AF in only 12 %. Individuals with a high cardiovascular risk (CVD) risk and high plasma-triglycerides seem particularly prone to develop AF upon n-3 PUFA supplementation. Therefore, we should exercise caution with n-3 PUFA supplementation especially in patients with higher age, CVD, hypertriglyceridemia or diabetes. In summary, existing data argue against the additive intake of n-3 PUFA for preventative purposes because of an incremental AF risk and lacking CVD benefits. However, more clinical studies are required to disentangle the discrepancy between n-3 PUFA RCTs and observational studies showing a lower CVD risk in individuals who regularly consume n-3 PUFA-rich fish.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":"345-352"},"PeriodicalIF":2.2,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140876066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Computerized diagnostic decision support systems - a comparative performance study of Isabel Pro vs. ChatGPT4. 计算机诊断决策支持系统--伊莎贝尔专业版与 ChatGPT4 的性能比较研究。
IF 2.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-07 eCollection Date: 2024-08-01 DOI: 10.1515/dx-2024-0033
Joe M Bridges

Objectives: Validate the diagnostic accuracy of the Artificial Intelligence Large Language Model ChatGPT4 by comparing diagnosis lists produced by ChatGPT4 to Isabel Pro.

Methods: This study used 201 cases, comparing ChatGPT4 to Isabel Pro. Systems inputs were identical. Mean Reciprocal Rank (MRR) compares the correct diagnosis's rank between systems. Isabel Pro ranks by the frequency with which the symptoms appear in the reference dataset. The mechanism ChatGPT4 uses to rank the diagnoses is unknown. A Wilcoxon Signed Rank Sum test failed to reject the null hypothesis.

Results: Both systems produced comprehensive differential diagnosis lists. Isabel Pro's list appears immediately upon submission, while ChatGPT4 takes several minutes. Isabel Pro produced 175 (87.1 %) correct diagnoses and ChatGPT4 165 (82.1 %). The MRR for ChatGPT4 was 0.428 (rank 2.31), and Isabel Pro was 0.389 (rank 2.57), an average rank of three for each. ChatGPT4 outperformed on Recall at Rank 1, 5, and 10, with Isabel Pro outperforming at 20, 30, and 40. The Wilcoxon Signed Rank Sum Test confirmed that the sample size was inadequate to conclude that the systems are equivalent. ChatGPT4 fabricated citations and DOIs, producing 145 correct references (87.9 %) but only 52 correct DOIs (31.5 %).

Conclusions: This study validates the promise of Clinical Diagnostic Decision Support Systems, including the Large Language Model form of artificial intelligence (AI). Until the issue of hallucination of references and, perhaps diagnoses, is resolved in favor of absolute accuracy, clinicians will make cautious use of Large Language Model systems in diagnosis, if at all.

目标: 验证人工智能大语言模型 ChatGPT4 的诊断准确性:通过比较人工智能大语言模型 ChatGPT4 和伊莎贝尔专业版的诊断列表,验证人工智能大语言模型 ChatGPT4 的诊断准确性:本研究使用 201 个病例,比较 ChatGPT4 和伊莎贝尔专业版。系统输入完全相同。平均互易等级(MRR)比较系统间正确诊断的等级。伊莎贝尔专业版根据症状在参考数据集中出现的频率进行排名。ChatGPT4 用来对诊断进行排序的机制尚不清楚。Wilcoxon Signed Rank Sum 检验未能拒绝零假设:结果:两个系统都生成了全面的鉴别诊断列表。伊莎贝尔专业版的列表在提交后立即显示,而 ChatGPT4 则需要几分钟。伊莎贝尔专业版的诊断正确率为 175%(87.1%),而 ChatGPT4 为 165%(82.1%)。ChatGPT4 的 MRR 为 0.428(排名 2.31),伊莎贝尔专业版的 MRR 为 0.389(排名 2.57),平均排名均为 3。ChatGPT4 在第 1、5 和 10 级的召回率上表现更好,而伊莎贝尔专业版在第 20、30 和 40 级的召回率上表现更好。Wilcoxon 符号秩和检验证实,样本量不足以得出这两个系统相当的结论。ChatGPT4 伪造了引用和 DOI,产生了 145 条正确的引用(87.9%),但只有 52 条正确的 DOI(31.5%):这项研究验证了临床诊断决策支持系统的前景,包括大语言模型形式的人工智能(AI)。在参考文献和诊断的幻觉问题得到解决之前,临床医生将谨慎使用大语言模型系统进行诊断(如果有的话)。
{"title":"Computerized diagnostic decision support systems - a comparative performance study of Isabel Pro vs. ChatGPT4.","authors":"Joe M Bridges","doi":"10.1515/dx-2024-0033","DOIUrl":"10.1515/dx-2024-0033","url":null,"abstract":"<p><strong>Objectives: </strong>Validate the diagnostic accuracy of the Artificial Intelligence Large Language Model ChatGPT4 by comparing diagnosis lists produced by ChatGPT4 to Isabel Pro.</p><p><strong>Methods: </strong>This study used 201 cases, comparing ChatGPT4 to Isabel Pro. Systems inputs were identical. Mean Reciprocal Rank (MRR) compares the correct diagnosis's rank between systems. Isabel Pro ranks by the frequency with which the symptoms appear in the reference dataset. The mechanism ChatGPT4 uses to rank the diagnoses is unknown. A Wilcoxon Signed Rank Sum test failed to reject the null hypothesis.</p><p><strong>Results: </strong>Both systems produced comprehensive differential diagnosis lists. Isabel Pro's list appears immediately upon submission, while ChatGPT4 takes several minutes. Isabel Pro produced 175 (87.1 %) correct diagnoses and ChatGPT4 165 (82.1 %). The MRR for ChatGPT4 was 0.428 (rank 2.31), and Isabel Pro was 0.389 (rank 2.57), an average rank of three for each. ChatGPT4 outperformed on Recall at Rank 1, 5, and 10, with Isabel Pro outperforming at 20, 30, and 40. The Wilcoxon Signed Rank Sum Test confirmed that the sample size was inadequate to conclude that the systems are equivalent. ChatGPT4 fabricated citations and DOIs, producing 145 correct references (87.9 %) but only 52 correct DOIs (31.5 %).</p><p><strong>Conclusions: </strong>This study validates the promise of Clinical Diagnostic Decision Support Systems, including the Large Language Model form of artificial intelligence (AI). Until the issue of hallucination of references and, perhaps diagnoses, is resolved in favor of absolute accuracy, clinicians will make cautious use of Large Language Model systems in diagnosis, if at all.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":"250-258"},"PeriodicalIF":2.2,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140848080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Computable phenotype for diagnostic error: developing the data schema for application of symptom-disease pair analysis of diagnostic error (SPADE). 诊断错误的可计算表型:为诊断错误的症状-疾病配对分析 (SPADE) 应用开发数据模式。
IF 2.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-03 eCollection Date: 2024-08-01 DOI: 10.1515/dx-2023-0138
Ahmed Hassoon, Charles Ng, Harold Lehmann, Hetal Rupani, Susan Peterson, Michael A Horberg, Ava L Liberman, Adam L Sharp, Michelle C Johansen, Kathy McDonald, J Mathrew Austin, David E Newman-Toker

Objectives: Diagnostic errors are the leading cause of preventable harm in clinical practice. Implementable tools to quantify and target this problem are needed. To address this gap, we aimed to generalize the Symptom-Disease Pair Analysis of Diagnostic Error (SPADE) framework by developing its computable phenotype and then demonstrated how that schema could be applied in multiple clinical contexts.

Methods: We created an information model for the SPADE processes, then mapped data fields from electronic health records (EHR) and claims data in use to that model to create the SPADE information model (intention) and the SPADE computable phenotype (extension). Later we validated the computable phenotype and tested it in four case studies in three different health systems to demonstrate its utility.

Results: We mapped and tested the SPADE computable phenotype in three different sites using four different case studies. We showed that data fields to compute an SPADE base measure are fully available in the EHR Data Warehouse for extraction and can operationalize the SPADE framework from provider and/or insurer perspective, and they could be implemented on numerous health systems for future work in monitor misdiagnosis-related harms.

Conclusions: Data for the SPADE base measure is readily available in EHR and administrative claims. The method of data extraction is potentially universally applicable, and the data extracted is conveniently available within a network system. Further study is needed to validate the computable phenotype across different settings with different data infrastructures.

目的:诊断错误是临床实践中造成可预防伤害的主要原因。我们需要可实施的工具来量化和解决这一问题。为了填补这一空白,我们旨在通过开发可计算表型来推广诊断错误的症状-疾病配对分析(SPADE)框架,然后演示如何将该模式应用于多种临床环境:方法:我们为 SPADE 流程创建了一个信息模型,然后将电子健康记录 (EHR) 中的数据字段和使用中的理赔数据映射到该模型中,从而创建了 SPADE 信息模型(意向)和 SPADE 可计算表型(扩展)。随后,我们对可计算表型进行了验证,并在三个不同医疗系统的四个案例研究中对其进行了测试,以证明其实用性:我们利用四个不同的案例研究,在三个不同的地点绘制并测试了 SPADE 可计算表型。我们发现,在电子病历数据仓库(EHR Data Warehouse)中完全可以提取用于计算 SPADE 基本衡量标准的数据字段,并且可以从提供者和/或保险公司的角度对 SPADE 框架进行操作:结论:SPADE 基础指标的数据可随时从电子病历和行政索赔中获取。数据提取方法可能具有普遍适用性,提取的数据可方便地在网络系统中使用。还需要进一步研究,以便在不同数据基础设施的不同环境中验证可计算的表型。
{"title":"Computable phenotype for diagnostic error: developing the data schema for application of symptom-disease pair analysis of diagnostic error (SPADE).","authors":"Ahmed Hassoon, Charles Ng, Harold Lehmann, Hetal Rupani, Susan Peterson, Michael A Horberg, Ava L Liberman, Adam L Sharp, Michelle C Johansen, Kathy McDonald, J Mathrew Austin, David E Newman-Toker","doi":"10.1515/dx-2023-0138","DOIUrl":"10.1515/dx-2023-0138","url":null,"abstract":"<p><strong>Objectives: </strong>Diagnostic errors are the leading cause of preventable harm in clinical practice. Implementable tools to quantify and target this problem are needed. To address this gap, we aimed to generalize the Symptom-Disease Pair Analysis of Diagnostic Error (SPADE) framework by developing its computable phenotype and then demonstrated how that schema could be applied in multiple clinical contexts.</p><p><strong>Methods: </strong>We created an information model for the SPADE processes, then mapped data fields from electronic health records (EHR) and claims data in use to that model to create the SPADE information model (intention) and the SPADE computable phenotype (extension). Later we validated the computable phenotype and tested it in four case studies in three different health systems to demonstrate its utility.</p><p><strong>Results: </strong>We mapped and tested the SPADE computable phenotype in three different sites using four different case studies. We showed that data fields to compute an SPADE base measure are fully available in the EHR Data Warehouse for extraction and can operationalize the SPADE framework from provider and/or insurer perspective, and they could be implemented on numerous health systems for future work in monitor misdiagnosis-related harms.</p><p><strong>Conclusions: </strong>Data for the SPADE base measure is readily available in EHR and administrative claims. The method of data extraction is potentially universally applicable, and the data extracted is conveniently available within a network system. Further study is needed to validate the computable phenotype across different settings with different data infrastructures.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":"295-302"},"PeriodicalIF":2.2,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11392038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140848588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are shortened aPTT values always to be attributed only to preanalytical problems? 缩短的 aPTT 值是否总是只能归因于分析前的问题?
IF 2.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-03 eCollection Date: 2024-11-01 DOI: 10.1515/dx-2024-0050
Vanja Radišić Biljak, Matea Tomas, Ivana Lapić, Andrea Saračević

Objectives: It has been recognized that shortened activated partial thromboplastin time (aPTT) may be caused by various preanalytical conditions. As coagulation Factor VIII is included in the in vitro intrinsic coagulation cascade measured by aPTT, we hypothesized that the shortened aPTT could be a result of elevated FVIII activity. We aimed to inspect the connection of elevated FVIII with shortened aPTT, and the possible effect inflammation has on routine laboratory parameters.

Methods: 40 patients from various hospital departments with aPTT measurement below the lower limit of the reference interval (<23.0 s) were included in the study. To compare the obtained results with aPTT measurements in the non-inflammatory state, samples from 25 volunteers (laboratory personnel) were collected. White blood cell count, C-reactive protein, aPTT, and FVIII values were measured in the control group.

Results: Only two samples among 40 patients with shortened aPTT (5 %) were clotted. Out of the remaining 38, 26 had FVIII activity above 150 % (upper limit of a reference interval), median value of 194 % (IQR: 143-243 %). Seven samples in the control group had shortened aPTT results (36 %). However, all coagulation samples were clot and hemolysis-free. Multiple regression identified only FVIII activity as an independent variable in predicting aPTT values (p=0.001).

Conclusions: Our results support the thesis that shortened aPTT is rarely a consequence of preanalytical problems. Elevated FVIII activity causes shortened aPTT, not only in the inflammatory state but also in individuals with concentration of inflammatory markers within reference intervals.

目的:人们已经认识到,活化部分凝血活酶时间(aPTT)缩短可能是由各种分析前条件造成的。由于凝血因子 VIII 包含在用 aPTT 测量的体外固有凝血级联中,我们假设 aPTT 缩短可能是 FVIII 活性升高的结果。我们的目的是研究 FVIII 升高与 aPTT 缩短之间的联系,以及炎症对常规实验室指标可能产生的影响:在 40 名 aPTT 缩短的患者中,只有 2 份样本(5%)出现凝血。其余 38 份样本中,26 份样本的 FVIII 活性高于 150%(参考区间上限),中位值为 194%(IQR:143-243%)。对照组中有 7 份样本的 aPTT 结果缩短(36%)。不过,所有凝血样本均无血块和溶血。多元回归确定只有 FVIII 活性是预测 aPTT 值的自变量(p=0.001):我们的研究结果支持这一观点,即 aPTT 缩短很少是分析前问题的结果。FVIII 活性升高不仅会导致炎症状态下的 aPTT 缩短,而且会导致炎症标志物浓度在参考区间内的个体的 aPTT 缩短。
{"title":"Are shortened aPTT values always to be attributed only to preanalytical problems?","authors":"Vanja Radišić Biljak, Matea Tomas, Ivana Lapić, Andrea Saračević","doi":"10.1515/dx-2024-0050","DOIUrl":"10.1515/dx-2024-0050","url":null,"abstract":"<p><strong>Objectives: </strong>It has been recognized that shortened activated partial thromboplastin time (aPTT) may be caused by various preanalytical conditions. As coagulation Factor VIII is included in the <i>in vitro</i> intrinsic coagulation cascade measured by aPTT, we hypothesized that the shortened aPTT could be a result of elevated FVIII activity. We aimed to inspect the connection of elevated FVIII with shortened aPTT, and the possible effect inflammation has on routine laboratory parameters.</p><p><strong>Methods: </strong>40 patients from various hospital departments with aPTT measurement below the lower limit of the reference interval (<23.0 s) were included in the study. To compare the obtained results with aPTT measurements in the non-inflammatory state, samples from 25 volunteers (laboratory personnel) were collected. White blood cell count, C-reactive protein, aPTT, and FVIII values were measured in the control group.</p><p><strong>Results: </strong>Only two samples among 40 patients with shortened aPTT (5 %) were clotted. Out of the remaining 38, 26 had FVIII activity above 150 % (upper limit of a reference interval), median value of 194 % (IQR: 143-243 %). Seven samples in the control group had shortened aPTT results (36 %). However, all coagulation samples were clot and hemolysis-free. Multiple regression identified only FVIII activity as an independent variable in predicting aPTT values (p=0.001).</p><p><strong>Conclusions: </strong>Our results support the thesis that shortened aPTT is rarely a consequence of preanalytical problems. Elevated FVIII activity causes shortened aPTT, not only in the inflammatory state but also in individuals with concentration of inflammatory markers within reference intervals.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":"430-434"},"PeriodicalIF":2.2,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140853391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative analysis of diagnostic accuracy in endodontic assessments: dental students vs. artificial intelligence. 牙髓病评估中诊断准确性的比较分析:牙科学生与人工智能。
IF 2.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-05-03 eCollection Date: 2024-08-01 DOI: 10.1515/dx-2024-0034
Abubaker Qutieshat, Alreem Al Rusheidi, Samiya Al Ghammari, Abdulghani Alarabi, Abdurahman Salem, Maja Zelihic

Objectives: This study evaluates the comparative diagnostic accuracy of dental students and artificial intelligence (AI), specifically a modified ChatGPT 4, in endodontic assessments related to pulpal and apical conditions. The findings are intended to offer insights into the potential role of AI in augmenting dental education.

Methods: Involving 109 dental students divided into junior (54) and senior (55) groups, the study compared their diagnostic accuracy against ChatGPT's across seven clinical scenarios. Juniors had the American Association of Endodontists (AEE) terminology assistance, while seniors relied on prior knowledge. Accuracy was measured against a gold standard by experienced endodontists, using statistical analysis including Kruskal-Wallis and Dwass-Steel-Critchlow-Fligner tests.

Results: ChatGPT achieved significantly higher accuracy (99.0 %) compared to seniors (79.7 %) and juniors (77.0 %). Median accuracy was 100.0 % for ChatGPT, 85.7 % for seniors, and 82.1 % for juniors. Statistical tests indicated significant differences between ChatGPT and both student groups (p<0.001), with no notable difference between the student cohorts.

Conclusions: The study reveals AI's capability to outperform dental students in diagnostic accuracy regarding endodontic assessments. This underscores AIs potential as a reference tool that students could utilize to enhance their understanding and diagnostic skills. Nevertheless, the potential for overreliance on AI, which may affect the development of critical analytical and decision-making abilities, necessitates a balanced integration of AI with human expertise and clinical judgement in dental education. Future research is essential to navigate the ethical and legal frameworks for incorporating AI tools such as ChatGPT into dental education and clinical practices effectively.

研究目的本研究评估了牙科学生和人工智能(AI),特别是经过修改的 ChatGPT 4,在牙髓和根尖条件相关的牙髓病学评估中的诊断准确性比较。研究结果旨在深入探讨人工智能在牙科教育中的潜在作用:该研究将 109 名牙科学生分为低年级组(54 人)和高年级组(55 人),比较了他们在七个临床场景中与 ChatGPT 的诊断准确性。低年级学生有美国牙髓病学家协会(AEE)的术语帮助,而高年级学生则依靠先前的知识。由经验丰富的牙髓病学家采用 Kruskal-Wallis 和 Dwass-Steel-Critchlow-Fligner 测试等统计分析方法,对照黄金标准来衡量准确性:与高年级学生(79.7%)和低年级学生(77.0%)相比,ChatGPT 的准确率(99.0%)明显更高。ChatGPT 的中位准确率为 100.0%,高年级为 85.7%,低年级为 82.1%。统计测试表明,ChatGPT 和两个学生组之间存在明显差异(p 结论:本研究揭示了人工智能在学习中的作用:这项研究揭示了人工智能在牙髓评估诊断准确性方面优于牙科学生的能力。这强调了人工智能作为一种参考工具的潜力,学生可以利用它来提高自己的理解能力和诊断技能。然而,过度依赖人工智能可能会影响关键分析和决策能力的发展,因此有必要在牙科教育中将人工智能与人类专业知识和临床判断平衡地结合起来。未来的研究对于将 ChatGPT 等人工智能工具有效融入口腔医学教育和临床实践的伦理和法律框架至关重要。
{"title":"Comparative analysis of diagnostic accuracy in endodontic assessments: dental students vs. artificial intelligence.","authors":"Abubaker Qutieshat, Alreem Al Rusheidi, Samiya Al Ghammari, Abdulghani Alarabi, Abdurahman Salem, Maja Zelihic","doi":"10.1515/dx-2024-0034","DOIUrl":"10.1515/dx-2024-0034","url":null,"abstract":"<p><strong>Objectives: </strong>This study evaluates the comparative diagnostic accuracy of dental students and artificial intelligence (AI), specifically a modified ChatGPT 4, in endodontic assessments related to pulpal and apical conditions. The findings are intended to offer insights into the potential role of AI in augmenting dental education.</p><p><strong>Methods: </strong>Involving 109 dental students divided into junior (54) and senior (55) groups, the study compared their diagnostic accuracy against ChatGPT's across seven clinical scenarios. Juniors had the American Association of Endodontists (AEE) terminology assistance, while seniors relied on prior knowledge. Accuracy was measured against a gold standard by experienced endodontists, using statistical analysis including Kruskal-Wallis and Dwass-Steel-Critchlow-Fligner tests.</p><p><strong>Results: </strong>ChatGPT achieved significantly higher accuracy (99.0 %) compared to seniors (79.7 %) and juniors (77.0 %). Median accuracy was 100.0 % for ChatGPT, 85.7 % for seniors, and 82.1 % for juniors. Statistical tests indicated significant differences between ChatGPT and both student groups (p<0.001), with no notable difference between the student cohorts.</p><p><strong>Conclusions: </strong>The study reveals AI's capability to outperform dental students in diagnostic accuracy regarding endodontic assessments. This underscores AIs potential as a reference tool that students could utilize to enhance their understanding and diagnostic skills. Nevertheless, the potential for overreliance on AI, which may affect the development of critical analytical and decision-making abilities, necessitates a balanced integration of AI with human expertise and clinical judgement in dental education. Future research is essential to navigate the ethical and legal frameworks for incorporating AI tools such as ChatGPT into dental education and clinical practices effectively.</p>","PeriodicalId":11273,"journal":{"name":"Diagnosis","volume":" ","pages":"259-265"},"PeriodicalIF":2.2,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140856356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Diagnosis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1